Emgrast 300mcg Injection
By Emgrast
Rx
1ml Injection in a Vial

Composition
Filgrastim(300mcg)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
July, 2025

liver
When using Emgrast 300mcg Injection, it is important to note that it has been deemed safe for patients with liver disease. In such cases, there is no specific need for dose adjustment when using this medication. If you have any concerns or questions regarding your liver health in relation to using Emgrast 300mcg Injection, it is advised to consult with your healthcare provider for personalized guidance.

kidney
Emgrast 300mcg Injection is considered safe for patients with kidney disease. There is no need to adjust the dosage of this injection based on kidney function.

alcohol
It is uncertain if it is safe to consume alcohol while using Emgrast 300mcg Injection. It is advised to consult your doctor for guidance.

driving
When using Emgrast 300mcg Injection, be cautious while driving as it can cause fatigue and affect your ability to drive.

pregnancy
Emgrast 300mcg Injection may not be safe during pregnancy. Animal studies suggest possible harm to the developing baby. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor regarding its use.

breastfeeding
Emgrast 300mcg Injection appears safe for breastfeeding based on limited data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Granulocyte Colony-Stimulating Factor |
Therapeutic Class | - |
Action Class | Granulocyte-colony stimulating factor (G-CSF) |
₹1299.1
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024